Management of helicobacter pylori-related disorders

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue SUPPL.1, 2012, Pages

  Misiewicz, J J ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

duodenal ulcer; gastric ulcer; Helicobacter pylori; peptic ulcer

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TINIDAZOLE; NITROIMIDAZOLE;

ARTICLE; DRUG EFFICACY; DUODENUM ULCER; DYSPEPSIA; ERADICATION THERAPY; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PEPTIC ULCER BLEEDING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; STOMACH CANCER; STOMACH LYMPHOMA; STOMACH ULCER; TREATMENT OUTCOME; CONFERENCE PAPER; DIGESTIVE SYSTEM ULCER; EARLY CANCER; FAMILY HISTORY; GASTROINTESTINAL DISEASE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; LONG TERM CARE; STOMACH SURGERY; UNITED STATES;

AMOXICILLIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NITROIMIDAZOLES; PROTON PUMPS;

EID: 0030915214     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-201204001-00005     Document Type: Article

References (12)

1. Malfertheiner P, Mégraud F, O'Morain C, et al.: Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. Eur J Gastroenterol Hepatol 1997, 9:1-2. (Pubitemid 27047348)
2. Freston IW: H-receptor antagonists and duodenal ulcer recurrerice: analysis of efficacy and commentary on safety, costs and patient selection. Am J Gastroenterol 1987, 82:1242-1240.
3. Mohammed J: The rationale of acid suppression in the treatment of acid-related disease. Ailment Pharimacol Ther 1994, 8 (suppl 1):3-10.
4. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA: Treatment of Helicobacter pylori reduces the rate of re-bleeding in peptic ulcer disease. Scand J Gastroenterol 1993, 28:939-942. (Pubitemid 23312236)
5. Labenz J, Borsch G: Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994, 55:19-23.
6. Rokkas T, Karameris A, Maurogeorgis A, Rallis E, Giannikos N: Eradication of Helicobacter pylon reduces the possibility of re-bleeding in peptic ulcer disease. Gastro Intest Endosc 1994, 41 :1-4.
7. Jaspersen D: Helicobacter pylori eradication: the best long- term prophylasis for ulcer bleeding recurrence? Endoscopy 1995, 27: 622-665.
8. Tolley NJ: A critique of therapeutic trials in Helicobacter pylori positive functional dyspepsia. Gastroenterology 1994, 106 1174-1183.
9. Kuipers EJ, Lundell L, Klinkenberg-Knol EL, et al.: Atrophic gastritis and Helicobacter pylori infection in patients with reflux oesophagitis treated with omeprazole or fundoplicalion. N Engl J Med 1996, 334: 1018-1022. (Pubitemid 26123777)
10. Penston JG, Mistry KR: Eradication of Helicobactor pylon in general practice. Ailment Pharmacol Ther 1996, 10:139-146.
11. Lancaster Smith MJ, Axon ATR, Ireland A: Ranitidine bismuth citrate in combination with clarithromycin either 250 mg qds or 500 mg bd eradicates Helicobacter pylori in up to 96% of patients with active duodenal ulcer disease [abstract]. Gut 1996, 39 (suppl 1 ):A33.
12. Dc Boer W: Helicobacter pylori: Studies on Epidemiology, Diagnosis and Therapy Amsterdam: Thesis, University of Amsterdam; 1996.